These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
84 related articles for article (PubMed ID: 6394257)
1. Circulatory uses of prostaglandins. Drug Ther Bull; 1984 Dec; 22(26):101-3. PubMed ID: 6394257 [No Abstract] [Full Text] [Related]
2. Use of prostaglandins in cardiopulmonary diseases of the newborn. Olley PM; Coceani F Semin Perinatol; 1980 Apr; 4(2):135-41. PubMed ID: 6990504 [No Abstract] [Full Text] [Related]
5. [Use of prostaglandin E1 in ductus-dependent congenital cardiopathies]. Marcial MB; Maluf M; Atik E; Vargas H; Baucia JA; Verginelli G Arq Bras Cardiol; 1983 Jun; 40(6):383-6. PubMed ID: 6686760 [No Abstract] [Full Text] [Related]
6. Prostaglandins and the management of congenital heart disease. Taylor WJ; Alpert BS Am Fam Physician; 1982 Dec; 26(6):127-32. PubMed ID: 6890758 [TBL] [Abstract][Full Text] [Related]
7. Treatment of cardiovascular disease with prostaglandins. Szczeklik A Vasa; 1984; 13(4):360-4. PubMed ID: 6393628 [No Abstract] [Full Text] [Related]
8. [Anesthesia for neonates and young infants with ductus dependent cardiac malformations treated with prostaglandin E1]. Fujii S; Nagai I; Yonei A; Sari A; Baba K Masui; 1984 May; 33(5):545-9. PubMed ID: 6540818 [No Abstract] [Full Text] [Related]
9. [Prostaglandin therapy in newborn infants with a Botalli duct-dependent circulation]. van der Sijp JR; Rohmer J Tijdschr Kindergeneeskd; 1985 Feb; 53(1):20-5. PubMed ID: 3857721 [TBL] [Abstract][Full Text] [Related]
10. [Long-term treatment using prostaglandin E2 in congenital heart defects with the pulmonary circulation being supplied by a patent ductus arteriosus]. Hruda J; Samánek M; First T; Vorísková M; Skovránek J Cesk Pediatr; 1985 May; 40(5):257-62. PubMed ID: 3860302 [No Abstract] [Full Text] [Related]
11. Administration of E-type prostaglandins in ductus-dependent congenital heart disease. Silove ED Pediatr Cardiol; 1982; 2(4):303-5. PubMed ID: 6956847 [No Abstract] [Full Text] [Related]
14. Morphologic features of the ductus arteriosus after prostaglandin E1 administration for ductus-dependent congenital heart defects. Park IS; Nihill MR; Titus JL J Am Coll Cardiol; 1983 Feb; 1(2 Pt 1):471-5. PubMed ID: 6681824 [No Abstract] [Full Text] [Related]
16. [Prospects for the use of prostaglandins in pediatric cardiology]. Zaorska B Kardiol Pol; 1981; 24(2):167-72. PubMed ID: 6788996 [No Abstract] [Full Text] [Related]
17. Comments on the pharmacologic manipulation of the ductus arteriosus in newborns. Rowe RD Adv Prostaglandin Thromboxane Res; 1978; 4():383-5. PubMed ID: 645513 [No Abstract] [Full Text] [Related]
18. [Use of prostaglandins and indomethacin in childhood cardiac therapy]. Gracián M; Castro FJ; Nieves G; Martínez-Villalta E; Mula JA; Guia JM An Esp Pediatr; 1988 Sep; 29 Suppl 32():214-7. PubMed ID: 3247946 [No Abstract] [Full Text] [Related]
19. Pathology of the ductus arteriosus treated with prostaglandins: comparisons with untreated cases. Calder AL; Kirker JA; Neutze JM; Starling MB Pediatr Cardiol; 1984; 5(2):85-92. PubMed ID: 6591146 [TBL] [Abstract][Full Text] [Related]